$EWTX
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.
Healthcare
Sector
Biotechnology
Industry
Kevin Koch
CEO
117
Employees
$46.53
Current Price
$2.90B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $201,786.73 | 4,442 | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $201,786.73 | 4,442 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $201,786.73 | 4,442 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $201,786.73 | 4,442 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $201,786.73 | 4,442 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | Nofi Michael Chief Financial Officer | Sale | 4,442 | $45.43 | $201,786.73 | View Details |
| Aug 13, 2026 | Donovan Joanne M. CMO | Sale | 2,919 | $43.41 | $126,703.57 | View Details |
31 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
Estimated-$0.53
ActualN/A
Revenue
Estimated$119.23M
ActualN/A
2 more earnings records available โ create a free account to see 12 months of history
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies:
$TRAW โ Traws Pharma, Inc.via ORBIMED ADVISORS LLC$QTTB โ Q32 Bio Inc.via ORBIMED ADVISORS LLC$PRLD โ Prelude Therapeutics Incvia ORBIMED ADVISORS LLC$STTK โ Shattuck Labs, Inc.via ORBIMED ADVISORS LLC$ACET โ Adicet Bio, Inc.via ORBIMED ADVISORS LLC$MBX โ MBX Biosciences, Inc.via ORBIMED ADVISORS LLC$ADRX โ ADARx Pharmaceuticals, Inc.via ORBIMED ADVISORS LLC$BLSM โ BlossomHill Therapeutics, Inc.via ORBIMED ADVISORS LLC$SCTX โ Scribe Therapeutics, Inc.via ORBIMED ADVISORS LLC$SION โ Sionna Therapeutics, Inc.via Thompson Peter A.